Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03077269 · ClinicalTrials.gov registry record
Understanding Coagulation and Inflammation in Burns
A clinical trial, sponsored by University of Rochester.
- Terminated
- Registry status
- 120
- Enrollment target
NCT03077269 is a clinical trial that was terminated before completion, run by University of Rochester. The registered enrollment target is 120 participants.
The verdict
NCT03077269 was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to understand what happens to platelets and blood clotting factors in burn patients over time. This study will also examine the role of microparticles (MPs), nanoparticles (NPs), and micro RNA in burns. The investigators will be looking at small particles of cells that are released into the blood. These particles have been found to be important in a variety of different diseases. The investigators believe that MPs, NPs, and micro RNA may play a role in development of inflammation, and infections in burn patients. Thus, hopefully, this study will help understand how to minimize transfusions and bleeding in burn patients as well as how to reduce inflammation and infections in burn patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-05-01 |
| Est. Completion | 2025-05-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03077269
The ClinicalTrials.gov registry entry for NCT03077269 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03077269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03077269 about?
NCT03077269 is a clinical study titled "Understanding Coagulation and Inflammation in Burns". The purpose of this study is to understand what happens to platelets and blood clotting factors in burn patients over time. This study will also examine the role of microparticles (MPs), nanoparticles (NPs), and micro RNA in burns. The investigators will be looking at small particles of cells that a...
What is the current status of trial NCT03077269?
This trial is currently terminated. The enrollment target is 120 participants. The study started on 2016-05-01. Estimated completion is 2025-05-19.
Who is sponsoring clinical trial NCT03077269?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.